Japan approves Alzheimer treatment Leqembi by Eisai and Biogen

Japan's Eisai said on Monday the country's health ministry had approved its Alzheimer treatment Leqembi, co-developed with U.S.-based Biogen. The drug is the first treatment shown to slow progression of the disease for people in the earlier stages of Alzheimer's. ( read original story ...)